References
- Newsom-Davis J. Neuromyotonia. Revue neurologique. 2004;160(5):85– 89.
- Maddison P. Neuromyotonia. Clin Neurophysiol. 2006;117(10):2118–2127.
- Watanabe O. [Isaacs's syndrome and associated diseases]. Rinsho shinkeigaku [Clinical Neurol.] 2013;53(11):1067–1070.
- Boccuti V, Perrone A, D'Introno A, et al. An unusual association of three autoimmune disorders: celiac disease, systemic lupus erythematosus and Hashimoto's thyroiditis. Auto- immun Highlights. 2016;7(1):1–3.
- Evoli A, Lancaster E. Paraneoplastic disorders in thymoma patients. J Thoracic Oncol: Off Publ Int Assoc Study Lung Cancer. 2014;9(9):S143–S7.
- Gonzalez G, Barros G, Russi ME, et al. Acquired neuromyotonia in childhood: case report and review. Pediatr Neurol. 2008;38(1):61–63.
- Ardissone A, Zorzi G, Ciano C, et al. Childhood onset of acquired neuromyotonia: association with a ganglioneuroma. Muscle Nerve.. 2015;51(4):620–621.
- Makri S, Maghnouche S, Ghiar B, et al. G.P.14.12 Neuromyotonia in childhood: Report of a case. Neuromuscul Disord. 2009;19(8/9):647–648.
- American Association of Electrodiagnostic Medicine glossary of terms in electrodiagnostic medicine. Muscle Nerve Suppl. 2001;10:S1–S50.
- Hahn AF, Parkes AW, Bolton CF, et al. Neuromyotonia in hereditary motor neuropathy. J Neurol, Neurosurg Psychiatry. 1991;54(3):230–235.
- Stockman AC, Dieltiens M, Janssens H, et al. Ocular neuromyotonia: case reports and literature review. Strabismus. 2018;26(3):133–141.
- Dankers W, Colin EM, van Hamburg JP, et al. Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential. Front Immunol. 2016;7:697–776.
- Woloszynska-Read A, Johnson CS, Trump DL. Vitamin D and cancer: clinical aspects. Best Pract Res Clin Endocrinol Metabol. 2011;25(4):605–615.
- Klein CJ, Lennon VA, Aston PA, et al. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology. 2012;79(11):1136–1144.